Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden
· Delayed Price · Currency is SEK 16.76
-0.38 (-2.22%)
At close: Mar 9, 2026
Cinclus Pharma Holding AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 487.25 | 566.72 | 87.97 | 173.55 | 138.2 | Upgrade
|
| Cash & Short-Term Investments | 487.25 | 566.72 | 87.97 | 173.55 | 138.2 | Upgrade
|
| Cash Growth | -14.02% | 544.20% | -49.31% | 25.57% | -33.72% | Upgrade
|
| Accounts Receivable | 16.06 | 4.58 | - | - | - | Upgrade
|
| Other Receivables | 4.99 | 2.93 | 3.98 | 10.23 | 1.38 | Upgrade
|
| Receivables | 21.05 | 7.51 | 3.98 | 10.23 | 1.38 | Upgrade
|
| Prepaid Expenses | 28.55 | 1.23 | 2.14 | 1.11 | 0.39 | Upgrade
|
| Other Current Assets | - | 25.02 | - | - | 5.38 | Upgrade
|
| Total Current Assets | 536.85 | 600.47 | 94.09 | 184.88 | 145.36 | Upgrade
|
| Property, Plant & Equipment | 9.41 | 0.54 | 0.32 | 0.89 | 1.82 | Upgrade
|
| Other Long-Term Assets | 0.3 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 546.56 | 601.01 | 94.41 | 185.77 | 147.18 | Upgrade
|
| Accounts Payable | 48.46 | 18.93 | 16.45 | 16.95 | 9.19 | Upgrade
|
| Accrued Expenses | 20.83 | 16.9 | 6.83 | 20.47 | 7.51 | Upgrade
|
| Short-Term Debt | - | - | 131.01 | - | - | Upgrade
|
| Current Portion of Leases | 3.11 | 0.11 | 0.02 | 0.54 | 0.85 | Upgrade
|
| Current Income Taxes Payable | 0.21 | 7.45 | 7.22 | 5.4 | - | Upgrade
|
| Current Unearned Revenue | 54.53 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 9.66 | 2.11 | 2.9 | 2.74 | 1.92 | Upgrade
|
| Total Current Liabilities | 136.79 | 45.49 | 164.42 | 46.1 | 19.47 | Upgrade
|
| Long-Term Leases | 4.79 | 0.19 | - | - | 0.61 | Upgrade
|
| Long-Term Unearned Revenue | 35.59 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | -0 | - | 6.79 | 12.8 | - | Upgrade
|
| Total Liabilities | 177.17 | 45.68 | 171.21 | 58.9 | 20.08 | Upgrade
|
| Common Stock | 0.92 | 0.92 | 0.51 | 0.51 | 0.26 | Upgrade
|
| Additional Paid-In Capital | 1,298 | 1,298 | 503.52 | 503.69 | 276.74 | Upgrade
|
| Retained Earnings | -952.8 | -772 | -606.84 | -394.16 | -145.08 | Upgrade
|
| Comprehensive Income & Other | 23.53 | 28.67 | 26 | 16.84 | -4.82 | Upgrade
|
| Shareholders' Equity | 369.39 | 555.33 | -76.8 | 126.87 | 127.1 | Upgrade
|
| Total Liabilities & Equity | 546.56 | 601.01 | 94.41 | 185.77 | 147.18 | Upgrade
|
| Total Debt | 7.9 | 0.3 | 131.03 | 0.54 | 1.46 | Upgrade
|
| Net Cash (Debt) | 479.36 | 566.42 | -43.06 | 173 | 136.75 | Upgrade
|
| Net Cash Growth | -15.37% | - | - | 26.51% | -34.41% | Upgrade
|
| Net Cash Per Share | 10.29 | 15.29 | -1.64 | 7.51 | 6.48 | Upgrade
|
| Filing Date Shares Outstanding | 46.54 | 46.54 | 26.23 | 0.33 | 0.26 | Upgrade
|
| Total Common Shares Outstanding | 46.54 | 46.54 | 26.23 | 0.33 | 0.26 | Upgrade
|
| Working Capital | 400.06 | 554.97 | -70.33 | 138.78 | 125.89 | Upgrade
|
| Book Value Per Share | 7.94 | 11.93 | -2.93 | 387.00 | 481.30 | Upgrade
|
| Tangible Book Value | 369.39 | 555.33 | -76.8 | 126.87 | 127.1 | Upgrade
|
| Tangible Book Value Per Share | 7.94 | 11.93 | -2.93 | 387.00 | 481.30 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.